Home News Cancer News Intrauterine Device Use May Reduce Incidence of Ovarian Cancer

Intrauterine Device Use May Reduce Incidence of Ovarian Cancer

Novel noncontraceptive benefit seen for all intrauterine devices

THURSDAY, Sept. 12, 2019 (HealthDay News) — Intrauterine device (IUD) use among reproductive women is associated with a decreased incidence of ovarian cancer, according to a review published online Sept. 10 in Obstetrics & Gynecology.

Lindsay J. Wheeler, M.D., from the University of Colorado in Aurora, and colleagues conducted a systematic literature review to explore the relationship between IUD use and risk for ovarian cancer.

The researchers identified 15 studies with individual-level data regarding IUD use and incident ovarian cancer and included 11 of these studies in a meta-analysis. Harmonization and weighting of the data showed ever use of an IUD was associated with a decreased risk for incident ovarian cancer (odds ratio, 0.68). No significant differences were found between covariates. Heterogeneity among all studies was found to be I² > 68 percent.

“Given the grave nature of an advanced ovarian cancer diagnosis, even a modest increase in the use of IUDs may lead to a decrease in incidence in ovarian cancer in a general population of women, leading to a significant population-level effect,” the authors write.

One author disclosed receiving funds from Merck, Bayer, and Sebela for contraceptive research trials.

Abstract/Full Text (subscription or payment may be required)

Copyright © 2019 HealthDay. All rights reserved.